Abstract
Purpose
The global prevalence of inflammatory bowel disease (IBD) has steadily risen over the past few decades. Bariatric surgery stands out as an effective strategy for inducing weight loss. This study investigated the impacts of bariatric surgery on the clinical outcomes in patients with IBD.
Materials and Methods
Data of hospitalized patients aged ≥ 18 years with IBD were extracted from the Nationwide Inpatient Sample (NIS) 2005–2018. The patients were categorized according to whether they underwent bariatric surgery or not. Univariate and multivariable logistic regression analyses were performed to determine the associations between bariatric surgery, prolonged LOS, unfavorable discharge, hospital mortality, and morbidity.
Results
Data from 807,843 hospitalized patients with IBD were extracted. After exclusions and propensity-score matching, 80,545 patients were analyzed, with 16,109 undergoing bariatric surgery and 64,436 not. A total of 23% of patients had a prolonged LOS, 8% had unfavorable discharge, and the mortality rate was 1.2%. Multivariable analyses revealed that, compared to patients without bariatric surgery, patients with bariatric surgery had significantly decreased odds of prolonged LOS (adjusted odds ratio [aOR], 0.89; 95% CI 0.85-0.93), unfavorable discharge (aOR, 0.83; 95% CI: 0.77-0.89), and mortality (aOR, 0.54; 95% CI: 0.44–0.67), but had increased odds of morbidity (aOR, 1.09; 95% CI 1.04–1.13).
Conclusion
In adults with IBD, bariatric surgery is associated with favorable outcomes concerning hospital LOS, discharge status, and mortality. However, the risk of overall morbidity is slightly increased in those who received bariatric surgery compared to those who did not.
Graphical Abstract
Similar content being viewed by others
Data Availability
All of the data supporting underlying findings are included in the manuscript and its supplemental files.
References
Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573–621.
Blumberg RS. Environment and genes: what is the interaction? Dig Dis. 2016;34(1-2):20–6.
Zand A, Nguyen A, Reynolds C, Khandadash A, Esrailian E, Hommes D. Patient experience and satisfaction with an e-health care management application for inflammatory bowel diseases. Int J Environ Res Public Health. 2021;18(22):11747.
Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL, Sung JJY, Kaplan GG. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–278.
Collaboration GBDCKD. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–33.
Singh S, Dulai PS, Zarrinpar A, Ramamoorthy S, Sandborn WJ. Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes. Nat Rev Gastroenterol Hepatol. 2017;14(2):110–21.
Bilski J, Mazur-Bialy A, Wojcik D, et al. Role of obesity, mesenteric adipose tissue, and adipokines in inflammatory bowel diseases. Biomolecules. 2019;9(12):780.
Kim JH, Oh CM, Yoo JH. Obesity and novel management of inflammatory bowel disease. World J Gastroenterol. 2023;29(12):1779–94.
Johnson AM, Loftus EV. Impact of obesity on the management of inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2020;16(7):350–9.
Benaiges D, Goday A, Pedro-Botet J, Mas A, Chillaron JJ, Flores-Le Roux JA. Bariatric surgery: to whom and when? Minerva Endocrinol. 2015;40(2):119–28.
Castagneto-Gissey L, Casella-Mariolo J, Mingrone G. Bariatric/Metabolic Surgery. Handb Exp Pharmacol. 2022;274:371–86.
Koh ZJ, Chew CAZ, Zhang JJY, et al. Metabolic outcomes after revisional bariatric surgery: a systematic review and meta-analysis. Surg Obes Relat Dis. 2020;16(10):1442–54.
Thomas DD, Anderson WA, Apovian CM, et al. Weight recidivism after Roux-en-Y gastric bypass surgery: an 11-year experience in a multiethnic medical center. Obesity (Silver Spring). 2019;27(2):217–25.
Angrisani L, Santonicola A, Iovino P, Formisano G, Buchwald H, Scopinaro N. Bariatric Surgery Worldwide 2013. Obes Surg. 2015;25(10):1822–32.
Arterburn DE, Telem DA, Kushner RF, Courcoulas AP. Benefits and risks of bariatric surgery in adults: a review. JAMA. 2020;324(9):879–87.
Stanford FC, Mushannen T, Cortez P, Campoverde Reyes KJ, Lee H, Gee DW, Pratt JS, Boepple PA, Bredella MA, Misra M, Singhal V. Comparison of short and long-term outcomes of metabolic and bariatric surgery in adolescents and adults. Front Endocrinol (Lausanne). 2020;11:157.
Healthcare Cost and Utilization Project (HCUP). HCUP facts and figures: statistics on hospital-based care in the United States, 2008 [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US), 2010.
Frigolet ME, Dong-Hoon K, Canizales-Quinteros S, Gutierrez-Aguilar R. Obesity, adipose tissue, and bariatric surgery. Bol Med Hosp Infant Mex. 2020;77(1):3–14.
Masi A, Fortini P, Krokidis MG, Romeo EF, Bascietto C, De Angelis P, Guglielmi V, Chatgilialoglu C. Increased levels of 5′,8-Cyclopurine DNA lesions in inflammatory bowel diseases. Redox Biol. 2020;34:101562.
Singh AK, Singh R, Kota SK. Bariatric surgery and diabetes remission: who would have thought it? Indian J Endocrinol Metab. 2015;19(5):563–76.
van Veldhuisen SL, Gorter TM, van Woerden G, et al. Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis. Eur Heart J. 2022;43(20):1955–69.
Istfan NW, Lipartia M, Anderson WA, Hess DT, Apovian CM. Approach to the patient: management of the post-bariatric surgery patient with weight regain. J Clin Endocrinol Metab. 2021;106(1):251–63.
Reenaers C, de Roover A, Kohnen L, Nachury M, Simon M, Pourcher G, Trang-Poisson C, Rajca S, Msika S, Viennot S, Alttwegg R, Serrero M, Seksik P, Peyrin-Biroulet L, Picon L, Bourbao Tournois C, Gontier R, Gilletta C, Stefanescu C, et al. Bariatric surgery in patients with inflammatory bowel disease: a case-control study from the GETAID. Inflamm Bowel Dis. 2022;28(8):1198–206.
Garg R, Mohan BP, Ponnada S, Singh A, Aminian A, Regueiro M, Click B. Safety and efficacy of bariatric surgery in inflammatory bowel disease patients: a systematic review and meta-analysis. Obes Surg. 2020;30(10):3872–83.
McGavigan AK, Garibay D, Henseler ZM, Chen J, Bettaieb A, Haj FG, Ley RE, Chouinard ML, Cummings BP. TGR5 contributes to glucoregulatory improvements after vertical sleeve gastrectomy in mice. Gut. 2017;66(2):226–34.
Ding L, Sousa KM, Jin L, Dong B, Kim BW, Ramirez R, Xiao Z, Gu Y, Yang Q, Wang J, Yu D, Pigazzi A, Schones D, Yang L, Moore D, Wang Z, Huang W. Vertical sleeve gastrectomy activates GPBAR-1/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice. Hepatology. 2016;64(3):760–73.
Wei W, Tian H, Fu X, Yao R, Su D. Long Non-Coding RNA (lncRNA) SNHG5 participates in vertical sleeve gastrectomy for type II diabetes mellitus by regulating TGR5. Med Sci Monit. 2020;26:e920628.
Garibay D, Zaborska KE, Shanahan M, Zheng Q, Kelly KM, Montrose DC, Dannenberg AJ, Miller AD, Sethupathy P, Cummings BP. TGR5 protects against colitis in mice, but vertical sleeve gastrectomy increases colitis severity. Obes Surg. 2019;29(5):1593–601.
Albaugh VL, Banan B, Ajouz H, Abumrad NN, Flynn CR. Bile acids and bariatric surgery. Mol Aspects Med. 2017;56:75–89.
Sharma P, McCarty TR, Njei B. Impact of bariatric surgery on outcomes of patients with inflammatory bowel disease: a nationwide inpatient sample analysis, 2004-2014. Obes Surg. 2018;28(4):1015–24.
Haal S, Guman MSS, Bruin S, et al. Risk factors for symptomatic gallstone disease and gallstone formation after bariatric surgery. Obes Surg. 2022;32(4):1270–8.
Dai Y, Luo B, Li W. Incidence and risk factors for cholelithiasis after bariatric surgery: a systematic review and meta-analysis. Lipids Health Dis. 2023;22(1):5.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical Approval
For this type of study, formal consent is not required.
Informed Consent
Informed consent does not apply.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key Points
• This study investigated the impact of bariatric surgery on hospitalization outcomes for patients with inflammatory bowel disease (IBD) using a large, nationally representative database.
• Bariatric surgery was independently associated with lower risks of prolonged LOS, unfavorable discharge, and hospital mortality.
• Patients who had received bariatric surgery were more likely to have morbidity during hospitalization than those who had not.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lin, IC., Liu, H. Impact of Bariatric Surgery on Outcomes of Patients with Inflammatory Bowel Disease: a Nationwide Inpatient Sample Analysis, 2005–2018. OBES SURG 34, 479–486 (2024). https://doi.org/10.1007/s11695-023-07023-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-023-07023-1